ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

“Tone” Of Statement Lacks Balance, Klausner Says

January 31, 1997

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

Psychiatric Society For Oncology/AIDS Formed; Holland Pres.

January 6, 1989

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

House Passes Cancer Bill With Mandates for NCI

September 28, 2012